JP2019513139A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513139A5
JP2019513139A5 JP2018550588A JP2018550588A JP2019513139A5 JP 2019513139 A5 JP2019513139 A5 JP 2019513139A5 JP 2018550588 A JP2018550588 A JP 2018550588A JP 2018550588 A JP2018550588 A JP 2018550588A JP 2019513139 A5 JP2019513139 A5 JP 2019513139A5
Authority
JP
Japan
Prior art keywords
solution
cyclodextrin
panobinostat
adduct
csf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018550588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513139A (ja
JP6880058B2 (ja
Filing date
Publication date
Priority claimed from GBGB1610440.8A external-priority patent/GB201610440D0/en
Application filed filed Critical
Priority claimed from PCT/EP2017/057472 external-priority patent/WO2017167837A1/en
Publication of JP2019513139A publication Critical patent/JP2019513139A/ja
Publication of JP2019513139A5 publication Critical patent/JP2019513139A5/ja
Application granted granted Critical
Publication of JP6880058B2 publication Critical patent/JP6880058B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018550588A 2016-03-31 2017-03-29 シクロデキストリン−パノビノスタット付加物 Active JP6880058B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201605406 2016-03-31
GB1605406.6 2016-03-31
GBGB1610440.8A GB201610440D0 (en) 2016-06-15 2016-06-15 Pharmaceutical formulations
GB1610440.8 2016-06-15
PCT/EP2017/057472 WO2017167837A1 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct

Publications (3)

Publication Number Publication Date
JP2019513139A JP2019513139A (ja) 2019-05-23
JP2019513139A5 true JP2019513139A5 (cg-RX-API-DMAC7.html) 2019-06-27
JP6880058B2 JP6880058B2 (ja) 2021-06-02

Family

ID=58489304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018550588A Active JP6880058B2 (ja) 2016-03-31 2017-03-29 シクロデキストリン−パノビノスタット付加物

Country Status (12)

Country Link
US (2) US10722597B2 (cg-RX-API-DMAC7.html)
EP (1) EP3347055B1 (cg-RX-API-DMAC7.html)
JP (1) JP6880058B2 (cg-RX-API-DMAC7.html)
KR (1) KR102416050B1 (cg-RX-API-DMAC7.html)
CN (1) CN109310783B (cg-RX-API-DMAC7.html)
AU (2) AU2017242544B2 (cg-RX-API-DMAC7.html)
CA (1) CA3018923A1 (cg-RX-API-DMAC7.html)
ES (1) ES2743740T3 (cg-RX-API-DMAC7.html)
MX (1) MX374165B (cg-RX-API-DMAC7.html)
PL (1) PL3347055T3 (cg-RX-API-DMAC7.html)
PT (1) PT3347055T (cg-RX-API-DMAC7.html)
WO (1) WO2017167837A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019000342A (es) * 2016-07-08 2019-09-04 Ranedis Pharmaceuticals Llc Composiciones y metodos para tratar y/o prevenir enfermedades de almacenamiento lisosomal y otras enfermedades metabolicas monogeneticas.
EP3560492B1 (en) * 2016-12-26 2023-11-29 FUJIFILM Corporation Lipid particle composition and pharmaceutical composition
GB202020359D0 (en) 2020-12-22 2021-02-03 Midatech Pharma Wales Ltd Pharmaceutical compositions and use thereof in combination therapy for brain cancer
EP4577210A1 (en) 2022-08-26 2025-07-02 Biodexa Ltd. Combination therapy for brain cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2685447C (en) 2000-08-10 2013-05-28 Takeda Pharmaceutical Company Limited Pharmaceutical composition
JP4922507B2 (ja) * 2000-08-10 2012-04-25 武田薬品工業株式会社 医薬組成物
SI1901729T1 (sl) 2005-05-13 2012-05-31 Topotarget Uk Ltd Farmacevtske formulacije HDAC inhibitorjev
JP2009535360A (ja) 2006-04-26 2009-10-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 高分子量神経治療薬の対流増加送達のための組成物および方法
EP2034978A1 (en) 2006-06-26 2009-03-18 Novartis AG Organic compounds
ITRM20070038A1 (it) * 2007-01-26 2008-07-27 Uni Degli Studi Di Roma La Sapienza Forme solubili di complessi di inclusione di inibitori dell istone deacetilasi e ciclodestrine loro processi di preparazione e impieghi in campo farmaceutico
CL2008002786A1 (es) * 2007-09-20 2009-05-15 Novartis Ag Torta farmceuticamente aceptable, formada por liofilizacion, que comprende: n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il]-etil]-amino]-metil]-fenil]-2e-2-propenamida o una sal, un regulador de ph seleciondo de lactato o acidop lactico, fodfato o acido fosforico o una combinacion y un agente de volumen; proceso de elaboracion.
GB201204263D0 (en) * 2012-03-12 2012-04-25 Renishaw Plc Giloma treatment
KR20170012555A (ko) * 2014-06-12 2017-02-02 더 유니버시티 오브 노트르 담 듀락 신경 질환 및 대뇌 상해의 치료를 위한 조성물 및 방법
GB201601773D0 (en) 2016-02-01 2016-03-16 Renishaw Plc Method

Similar Documents

Publication Publication Date Title
Lacroce et al. Polymer-based thermoresponsive hydrogels for controlled drug delivery
Liu et al. Mesoporous silica coated single‐walled carbon nanotubes as a multifunctional light‐responsive platform for cancer combination therapy
JP2011519932A5 (cg-RX-API-DMAC7.html)
EA201890836A1 (ru) Инъекционные составы нейростероида, содержащие наночастицы
Li et al. Dual‐modal NIR‐fluorophore conjugated magnetic nanoparticle for imaging amyloid‐β species in vivo
ES2991516T3 (es) Métodos para tratar tumores de restos adrenales testiculares y ováricos
CN105228652A (zh) 评价全脑血管旁路径的废弃物清除功能的方法以及基于这种方法治疗神经退化性病症的方法
Zou et al. Innovations and applications of composite hydrogels: from polymer‐based systems to metal‐ion‐doped and functional nanomaterial‐enhanced architectures
CN105012251A (zh) 注射用紫杉烷类药物白蛋白纳米粒冻干制剂及制备方法
RU2014101036A (ru) Стабилизированная композиция вориконазола
Hong et al. In vivo fluorescence imaging in the second near-infrared window using carbon nanotubes
CN105617526B (zh) 一种溶胀型丝素蛋白微针给药系统及其制备方法
Zhang et al. Therapeutic potential of injectable supramolecular hydrogels with neural stem cell exosomes and hydroxypropyl methylcellulose for post-stroke neurological recovery
RU2016107610A (ru) Фармацевтическая композиция
Lu et al. PEGylated PAMAM dendrimer nanoplatform for co-delivery of chemotherapeutic agents and inorganic nanoparticles enhancing chemo-photothermal combination therapy
TWI616210B (zh) 經修飾微氣泡及其製備方法
MX374165B (es) Aducto de ciclodextrina-panobinostat
Bal et al. Central nervous system imaging in diabetic cerebrovascular diseases and white matter hyperintensities
Thevenot et al. Polymersomes for theranostics
CN106389311A (zh) 一种重酒石酸去甲肾上腺素的药物组合物
WO2017093902A1 (en) A process for the preparation of nanoparticles for use as contrast agents in the magnetic resonance imaging
US10617760B2 (en) Composition for target-specific photothermal therapy
KR101474063B1 (ko) 피브린 표적 펩타이드 서열이 결합된 글라이콜 키토산-금 나노입자를 포함하는 혈전 탐지용 ct 조영제
CN109157512B (zh) 一种莪术醇衍生物纳米晶的制备方法
CN108096280A (zh) 一种神经干细胞滴鼻剂